Literature DB >> 28199703

The Effect of Substance Use on 10-Year Outcome in First-Episode Psychosis.

Melissa A Weibell1,2, Wenche Ten Velden Hegelstad1, Bjørn Auestad3,4, Jørgen Bramness5,6, Julie Evensen7, Ulrik Haahr8, Inge Joa1,2, Jan Olav Johannessen1,2, Tor Ketil Larsen1,9, Ingrid Melle6,7, Stein Opjordsmoen6,7, Bjørn Rishovd Rund10,11, Erik Simonsen8,12, Per Vaglum6,7, Thomas McGlashan13, Patrick McGorry14,15, Svein Friis6,7.   

Abstract

Substance use is common in first-episode psychosis (FEP) and has been linked to poorer outcomes with more severe psychopathology and higher relapse rates. Early substance discontinuation appears to improve symptoms and function. However, studies vary widely in their methodology, and few have examined patients longitudinally, making it difficult to draw conclusions for practice and treatment. We aimed to investigate the relationship between substance use and early abstinence and the long-term course of illness in a representative sample of FEP patients. Out of 301 included patients, 266 could be divided into 4 groups based on substance use patterns during the first 2 years of treatment: persistent users, episodic users, stop-users and nonusers. Differences in clinical and functional measures during the follow-up period were assessed using linear mixed effects models for the analysis of repeated measures data. Patients who stopped using substances within the first 2 years after diagnosis had outcomes similar to those who had never used with fewer symptoms than episodic or persistent users. Both episodic and persistent users had lower rates of symptom remission than nonusers, and persistent users also had more negative symptoms than those who stopped using. Our findings emerge from one of very few long-term longitudinal studies examining substance use cessation in FEP with 10-year follow-up. The results convey hope that the detrimental effects of substance abuse on mental health may be significantly reversed if one stops the abuse in time. This can help patients who struggle with addiction with their motivation to embrace abstinence.
© The Author 2017. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  negative symptoms; psychosis; schizophrenia; substance abuse

Mesh:

Year:  2017        PMID: 28199703      PMCID: PMC5472130          DOI: 10.1093/schbul/sbw179

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  44 in total

1.  Anhedonia and amotivation in psychiatric outpatients with fully remitted stimulant use disorder.

Authors:  Adam M Leventhal; Christopher W Kahler; Lara A Ray; Kristen Stone; Diane Young; Iwona Chelminski; Mark Zimmerman
Journal:  Am J Addict       Date:  2008 May-Jun

2.  Course of substance misuse and daily tobacco use in first-episode psychosis.

Authors:  Darryl Wade; Susy Harrigan; Jane Edwards; Philip M Burgess; Greg Whelan; Patrick D McGorry
Journal:  Schizophr Res       Date:  2005-11-17       Impact factor: 4.939

3.  Does giving up substance use work for patients with psychosis? A systematic meta-analysis.

Authors:  Katherine Mullin; Pal Gupta; Michael T Compton; Olav Nielssen; Anthony Harris; Matthew Large
Journal:  Aust N Z J Psychiatry       Date:  2012-02-24       Impact factor: 5.744

Review 4.  Secondary negative symptoms - A review of mechanisms, assessment and treatment.

Authors:  Matthias Kirschner; André Aleman; Stefan Kaiser
Journal:  Schizophr Res       Date:  2016-05-24       Impact factor: 4.939

5.  Cannabis abuse and the course of recent-onset schizophrenic disorders.

Authors:  D H Linszen; P M Dingemans; M E Lenior
Journal:  Arch Gen Psychiatry       Date:  1994-04

6.  Premorbid adjustment in first-episode non-affective psychosis: distinct patterns of pre-onset course.

Authors:  Tor K Larsen; Svein Friis; Ulrik Haahr; Jan Olav Johannessen; Ingrid Melle; Stein Opjordsmoen; Bjørn Rishovd Rund; Erik Simonsen; Per Vaglum Vaglum; Thomas H McGlashan
Journal:  Br J Psychiatry       Date:  2004-08       Impact factor: 9.319

7.  Substance use and the course of early psychosis: a 2-year follow-up of first-admitted subjects.

Authors:  F Sorbara; F Liraud; F Assens; F Abalan; H Verdoux
Journal:  Eur Psychiatry       Date:  2003-05       Impact factor: 5.361

8.  A 12-month prospective follow-up study of patients with schizophrenia-spectrum disorders and substance abuse: changes in psychiatric symptoms and substance use.

Authors:  Howard C Margolese; Juan Carlos Negrete; Raymond Tempier; Kathryn Gill
Journal:  Schizophr Res       Date:  2006-02-07       Impact factor: 4.939

9.  Cannabis and first-episode psychosis: different long-term outcomes depending on continued or discontinued use.

Authors:  Ana González-Pinto; Susana Alberich; Sara Barbeito; Miguel Gutierrez; Patricia Vega; Berta Ibáñez; Mahmoud Karim Haidar; Eduard Vieta; Celso Arango
Journal:  Schizophr Bull       Date:  2009-11-13       Impact factor: 9.306

10.  Naturalistic follow-up of co-morbid substance use in schizophrenia: the West London first-episode study.

Authors:  I Harrison; E M Joyce; S H Mutsatsa; S B Hutton; V Huddy; M Kapasi; T R E Barnes
Journal:  Psychol Med       Date:  2007-05-29       Impact factor: 7.723

View more
  6 in total

1.  Performance in Practice: Practice Assessment Tool for the Care of Patients With Schizophrenia.

Authors:  Laura J Fochtmann; Jennifer Medicus; Seung-Hee Hong
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-11-05

2.  Barriers and Facilitators That Influence Providers' Ability to Educate, Monitor, and Treat Substance Use in First-Episode Psychosis Programs Using the Theoretical Domains Framework.

Authors:  Oladunni Oluwoye; Elizabeth Fraser
Journal:  Qual Health Res       Date:  2021-02-16

3.  Symptom remission at 12-weeks strongly predicts long-term recovery from the first episode of psychosis.

Authors:  Paola Dazzan; Julia M Lappin; Margaret Heslin; Kim Donoghue; Ben Lomas; Uli Reininghaus; Adanna Onyejiaka; Tim Croudace; Peter B Jones; Robin M Murray; Paul Fearon; Gillian A Doody; Craig Morgan
Journal:  Psychol Med       Date:  2019-07-25       Impact factor: 7.723

4.  Comorbid opioid use is undertreated among forensic patients with schizophrenia.

Authors:  Kristiina Kivimies; Eila Repo-Tiihonen; Hannu Kautiainen; Jari Tiihonen
Journal:  Subst Abuse Treat Prev Policy       Date:  2018-11-06

Review 5.  First-episode psychosis: How long does it last? A review of evolution and trajectory.

Authors:  Jyoti Prakash; K Chatterjee; K Srivastava; V S Chauhan
Journal:  Ind Psychiatry J       Date:  2021-07-20

Review 6.  Is It Possible to Predict the Future in First-Episode Psychosis?

Authors:  Jaana Suvisaari; Outi Mantere; Jaakko Keinänen; Teemu Mäntylä; Eva Rikandi; Maija Lindgren; Tuula Kieseppä; Tuukka T Raij
Journal:  Front Psychiatry       Date:  2018-11-13       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.